# Cyclophosphamide Drug Interaction Study In Cancer Patients

> **NCT00334646** · PHASE1 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 25 (actual)

## Conditions studied

- Nausea and Vomiting, Chemotherapy-Induced

## Interventions

- **DRUG:** Oral GW679769
- **DRUG:** IV Cyclophosphamide 500-700mg/m2

## Key facts

- **NCT ID:** NCT00334646
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-08-10
- **Primary completion:** 2009-10-14
- **Final completion:** 2009-10-14
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** compound terminated
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00334646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00334646, "Cyclophosphamide Drug Interaction Study In Cancer Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00334646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*